Luminate: Completed Phase IIb enrollment

Allegro completed enrollment of 120 patients in the double-blind, placebo-controlled, U.S. Phase IIb DEL MAR trial comparing 1, 2 and 3 mg intravitreal Luminate vs. Avastin bevacizumab. Patients will receive Luminate or Avastin at day 0 and weeks 4 and 8. Patients may receive Luminate as needed at week 20 and Avastin as needed at weeks 12, 16 and 20. ...